Copd Exacerbation

Patients admitted to the hospitalization for chronic obstructive pulmonary disease are at increased risk for discontinuation of long-acting inhaler medications upon discharge and transition to home, according to results published in CHEST.

Preceding hospitalization for acute COPD exacerbation was associated with increased risk for 90-day and overall mortality of cardiovascular events, according to a study published in CHEST.

An additional course of ciprofloxacin 14 days after an unresolved COPD exacerbation did not benefit time to next event, compared with placebo, in patients with persistent symptoms and elevated C-reactive protein, according to recent data.

The FDA Pulmonary-Allergy Drugs Advisory Committee voted 14-1 against a proposed labeling claim that Trelegy Ellipta reduces all-cause mortality in patients with COPD.

Patients hospitalized for a COPD exacerbation who participated in pulmonary rehabilitation within 90 days of discharge had a lower rate of readmission within 1 year, according to new data.

Nuvaira Inc. announced that its targeted lung denervation system for patients with COPD has been designated as a breakthrough device by the FDA.

Healio Pulmonology has compiled a list of recent news highlighting research in COPD.

New data suggest that methamphetamine users may be more likely to be hospitalized for pulmonary diseases such as pneumonia and acute respiratory failure.

NEW ORLEANS — An uptick in hospitalizations and deaths related to COPD exacerbations during the coldest months of the year — January, February and March — places a significant burden on health care resources, researchers reported at the CHEST Annual Meeting.